Clinic vs Clinic+Community Outreach HPV Self-Collection to Increase Cervical Screening in Women With HIV

Recruiting N/A Interventional Study
Cervix Cancer HIV Infections HPV Infection
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
25 – 49
Sex
Female
Study type
Interventional
Purpose
Screening
Participants needed
7,597 (estimated)
Sponsor
UNC Lineberger Comprehensive Cancer Center · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This Clinical Trials Network for Human Immunodeficiency Virus (HIV)-Associated Cervical Cancer Screening and Treatment Optimization (CASCADE) C3001-A trial aims to assess how the introduction of a community-health-worker-facilitated model, in addition to the existing static clinic-only model, influences the rates of cervical cancer screening uptake among women living with HIV (WLWH). This study in…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Clinic Inclusion Criteria * Clinics selected for inclusion will include those clinics that provide Human Immunodeficiency Virus (HIV) care and distribute antiretroviral therapy (ART) to Women living with Human Immunodeficiency Virus (WLWH. * These clinics should also have the ability to collect the…
Contacts

Jennifer S Smith, PhD

919-966-4432

jennifers@unc.edu

CONTACT

Franklin K Okwunze, MD

kokwunze@unc.edu

CONTACT